Gilead Sciences Inc Sustainability Reports

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The company focuses primarily on treatments for HIV, viral hepatitis, COVID-19, and oncology.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 549300WTZWR07K8MNV44

FIGI: BBG001S6Y1X7

18 reports from 2014 to 2025

• Gilead Sciences Inc 2025 Form 10-K Annual Report
• Gilead Sciences Inc 2025 Responsible Business and Impact Report
• Gilead Sciences Inc 2024 Modern Slavery Statement
• Gilead Sciences Inc 2024 Task Force on Climate-Related Financial Disclosures (TCFD) Summary Report
• Gilead Sciences Inc 2024 Responsible Business and Impact Report